Vyteris wants to give up drug-delivery ghost

The drug-delivery business isn't for everybody. And New Jersey-based Vyteris wants out, according to an article on in-PharmaTechnologist. Vyteris is hanging a "for sale" sign on its adhesive, patch-based technology platform. The future for Vyteris, the company says, is in acquiring contract research organizations. Vyteris no doubt does see CROs as a good investment, but, as in-PharmaTechnologist points out, there's probably more to the story. "However, while recognition of these trends was undoubtedly a motivation, Vyteris' decision to refocus as a CRO also reflects the difficulties it has had with its delivery technology business," the article says. Read it all here